Singer DE - Search Results

1

Efficacy and safety of rivaroxaban compared with warfarin among elderly patients with nonvalvular atrial fibrillation in the Rivaroxaban Once Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation (ROCKET AF).

Halperin JL, Hankey GJ, Wojdyla DM, Piccini JP, Lokhnygina Y, Patel MR, Breithardt G, Singer DE, Becker RC, Hacke W, Paolini JF, Nessel CC, Mahaffey KW, Califf RM, Fox KA; ROCKET AF Steering Committee and Investigators. Halperin JL, et al. Among authors: singer de. Circulation. 2014 Jul 8;130(2):138-46. doi: 10.1161/CIRCULATIONAHA.113.005008. Epub 2014 Jun 3. Circulation. 2014. PMID: 24895454 Free article. Clinical Trial.

2

The effect of aspirin on the risk of stroke in patients with nonrheumatic atrial fibrillation: The BAATAF Study.

Singer DE, Hughes RA, Gress DR, Sheehan MA, Oertel LB, Maraventano SW, Blewett DR, Rosner B, Kistler JP. Singer DE, et al. Am Heart J. 1992 Dec;124(6):1567-73. doi: 10.1016/0002-8703(92)90074-6. Am Heart J. 1992. PMID: 1462916 Clinical Trial.

3

The impact of long-term warfarin therapy on quality of life. Evidence from a randomized trial. Boston Area Anticoagulation Trial for Atrial Fibrillation Investigators.

Lancaster TR, Singer DE, Sheehan MA, Oertel LB, Maraventano SW, Hughes RA, Kistler JP. Lancaster TR, et al. Among authors: singer de. Arch Intern Med. 1991 Oct;151(10):1944-9. Arch Intern Med. 1991. PMID: 1929681 Clinical Trial.

4

Overview of the randomized trials to prevent stroke in atrial fibrillation.

Singer DE. Singer DE. Ann Epidemiol. 1993 Sep;3(5):563-7. doi: 10.1016/1047-2797(93)90117-m. Ann Epidemiol. 1993. PMID: 8167838

5

An analysis of the lowest effective intensity of prophylactic anticoagulation for patients with nonrheumatic atrial fibrillation.

Hylek EM, Skates SJ, Sheehan MA, Singer DE. Hylek EM, et al. Among authors: singer de. N Engl J Med. 1996 Aug 22;335(8):540-6. doi: 10.1056/NEJM199608223350802. N Engl J Med. 1996. PMID: 8678931 Free article.

6

Anticoagulation for atrial fibrillation: epidemiology informing a difficult clinical decision.

Singer DE. Singer DE. Proc Assoc Am Physicians. 1996 Jan;108(1):29-36. Proc Assoc Am Physicians. 1996. PMID: 8834062 Review.

7

Preventing stroke in atrial fibrillation.

Wolf PA, Singer DE. Wolf PA, et al. Among authors: singer de. Am Fam Physician. 1997 Dec;56(9):2242-50. Am Fam Physician. 1997. PMID: 9402810 Review.

8

Anticoagulation to prevent stroke in atrial fibrillation and its implications for managed care.

Singer DE. Singer DE. Am J Cardiol. 1998 Mar 12;81(5A):35C-40C. doi: 10.1016/s0002-9149(98)00185-4. Am J Cardiol. 1998. PMID: 9525571

9

Recent national patterns of warfarin use in atrial fibrillation.

Stafford RS, Singer DE. Stafford RS, et al. Among authors: singer de. Circulation. 1998 Apr 7;97(13):1231-3. doi: 10.1161/01.cir.97.13.1231. Circulation. 1998. PMID: 9570191

10

Prospective study of the outcomes of ambulatory patients with excessive warfarin anticoagulation.

Hylek EM, Chang YC, Skates SJ, Hughes RA, Singer DE. Hylek EM, et al. Among authors: singer de. Arch Intern Med. 2000 Jun 12;160(11):1612-7. doi: 10.1001/archinte.160.11.1612. Arch Intern Med. 2000. PMID: 10847254

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

446 results

Search Page